|
1
|
Qu Y, Che N, Zhao D, Zhang C, Su D, Zhou
L, Zhang L, Wang C, Zhang H and Wei L: The clinicopathological
significance of ALK rearrangements and KRAS and EGFR mutations in
primary pulmonary mucinous adenocarcinoma. Tumour Biol.
36:6417–6424. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cai D, Li H, Wang R, Li Y, Pan Y, Hu H,
Zhang Y, Gong R, Pan B, Sun Y and Chen H: Comparison of clinical
features, molecular alterations and prognosis in morphological
subgroups of lung invasive mucinous adenocarcinoma. Onco Targets
Ther. 7:2127–2132. 2014.PubMed/NCBI
|
|
3
|
Sambrook-Gowar FJ: An unusual mucous cyst
of the lung. Thorax. 33:796–799. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kragel PJ, Devaney KO, Meth BM, Linnoila
I, Frierson HF Jr and Travis WD: Mucinous cystadenoma of the lung.
A report of two cases with immunohistochemical and ultrastructural
analysis. Arch Pathol Lab Med. 114:1053–1056. 1990.PubMed/NCBI
|
|
5
|
Gaikwad A, Gupta A, Hare S, Gomes M,
Sekhon H, Souza C, Inacio J, Lad S and Seely J: Primary
adenocarcinoma of lung: A pictorial review of recent updates. Eur J
Radiol. 81:4146–4155. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Travis WD, Brambilla E, Nicholson AG,
Yatabe Y, Austin JHM, Beasley MB, Chirieac LR, Dacic S, Duhig E,
Flieder DB, et al: The 2015 world health organization
classification of lung tumors: Impact of genetic, clinical and
radiologic advances since the 2004 classification. J Thorac Oncol.
10:1243–1260. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Casali C, Rossi G, Marchioni A, Sartori G,
Maselli F, Longo L, Tallarico E and Morandi U: A single
institution-based retrospective study of surgically treated
bronchioloalveolar adenocarcinoma of the lung: Clinicopathologic
analysis, molecular features and possible pitfalls in routine
practice. J Thorac Oncol. 5:830–836. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang Y, Sun Y, Xiang J, Zhang Y, Hu H and
Chen H: A clinicopathologic prediction model for postoperative
recurrence in stage Ia non-small cell lung cancer. J Thorac
Cardiovasc Surg. 148:1193–1199. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hwang DH, Sholl LM, Rojas-Rudilla V, Hall
DL, Shivdasani P, Garcia EP, MacConaill LE, Vivero M, Hornick JL,
Kuo FC, et al: KRAS and NKX2-1 mutations in invasive mucinous
adenocarcinoma of the lung. J Thorac Oncol. 11:496–503. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rao G, Pierobon M, Kim IK, Hsu WH, Deng J,
Moon YW, Petricoin EF, Zhang YW, Wang Y and Giaccone G: Inhibition
of AKT1 signaling promotes invasion and metastasis of non-small
cell lung cancer cells with K-RAS or EGFR mutations. Sci Rep.
7:70662017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Minamimoto R, Jamali M, Gevaert O,
Echegaray S, Khuong A, Hoang CD, Shrager JB, Plevritis SK, Rubin
DL, Leung AN, et al: Prediction of EGFR and KRAS mutation in
non-small cell lung cancer using quantitative 18F FDG-PET/CT
metrics. Oncotarget. 8:52792–52801. 2017.PubMed/NCBI
|
|
12
|
Kamata T, Yoshida A, Shiraishi K, Furuta
K, Kosuge T, Watanabe S, Asamura H and Tsuta K: Mucinous
micropapillary pattern in lung adenocarcinomas: A unique histology
with genetic correlates. Histopathology. 68:356–366. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ichinokawa H, Ishii G, Nagai K, Kawase A,
Yoshida J, Nishimura M, Hishida T, Ogasawara N, Tsuchihara K and
Ochiai A: Distinct clinicopathologic characteristics of lung
mucinous adenocarcinoma with KRAS mutation. Hum Pathol.
44:2636–2642. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Travis WD, Brambilla E, Noguchi M,
Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ,
Van-Schil PE, et al: International association for the study of
lung cancer/american thoracic society/european respiratory society
international multidisciplinary classification of lung
adenocarcinoma. J Thorac Oncol. 6:244–285. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sakuma Y, Matsukuma S, Yoshihara M,
Nakamura Y, Noda K, Nakayama H, Kameda Y, Tsuchiya E and Miyagi Y:
Distinctive evaluation of nonmucinous and mucinous subtypes of
bronchioloalveolar carcinomas in EGFR and K-ras gene-mutation
analyses for Japanese lung adenocarcinomas: Confirmation of the
correlations with histologic subtypes and gene mutations. Am J Clin
Pathol. 128:100–108. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yoshizawa A, Motoi N, Riely GJ, Sima CS,
Gerald WL, Kris MG, Park BJ, Rusch VW and Travis WD: Impact of
proposed IASLC/ATS/ERS classification of lung adenocarcinoma:
prognostic subgroups and implications for further revision of
staging based on analysis of 514 stage I cases. Mod Pathol.
24:653–664. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Warth A, Muley T, Meister M, Stenzinger A,
Thomas M, Schirmacher P, Schnabel PA, Budczies J, Hoffmann H and
Weichert W: The novel histologic International association for the
study of lung Cancer/American thoracic society/European respiratory
society classification system of lung adenocarcinoma is a
stage-independent predictor of survival. J Clin Oncol.
30:1438–1446. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tsuta K, Kawago M, Inoue E, Yoshida A,
Takahashi F, Sakurai H, Watanabe S, Takeuchi M, Furuta K, Asamura H
and Tsuda H: The utility of the proposed IASLC/ATS/ERS lung
adenocarcinoma subtypes for disease prognosis and correlation of
driver gene alterations. Lung Cancer. 81:371–376. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cadranel J, Quoix E, Baudrin L,
Mourlanette P, Moro-Sibilot D, Morere JF, Souquet PJ, Soria JC,
Morin F and Milleron B; IFCT-0401 Trial Group, : IFCT-0401 Trial: A
phase II study of gefitinib administered as first-line treatment in
advanced adenocarcinoma with bronchioloalveolar carcinoma subtype.
J Thorac Oncol. 4:1126–1135. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Righi L, Vatrano S, Di-Nicolantonio F,
Massa F, Rossi G, Cavazza A, Volante M, Votta A, Izzo S, Lo-Iacono
M, et al: Retrospective multicenter study investigating the role of
targeted next-generation sequencing of selected cancer genes in
mucinous adenocarcinoma of the lung. J Thorac Oncol. 11:504–515.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Geles A, Gruber-Moesenbacher U, ManzlC F,
Al Effah M, Grygar E, Juettner-Smolle F and Popper HH: Pulmonary
mucinous adenocarcinomas: Architectural patterns in correlation
with genetic changes, prognosis and survival. Virchows Arch.
467:675–686. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kunii R, Jiang S, Hasegawa G, Yamamoto T,
Umezu H, Watanabe T, Tsuchida M, Hashimoto T, Hamakubo T, Kodama T,
et al: The predominant expression of hepatocyte nuclear factor 4α
(HNF4α) in thyroid transcription factor-1 (TTF-1)-negative
pulmonary adenocarcinoma. Histopathology. 58:467–476. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Finberg KE, Sequist LV, Joshi VA,
Muzikansky A, Miller JM, Han M, Beheshti J, Chirieac LR, Mark EJ
and Iafrate AJ: Mucinous differentiation correlates with absence of
EGFR mutation and presence of KRAS mutation in lung adenocarcinomas
with bronchioloalveolar features. J Mol Diagn. 9:320–326. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Watanabe H, Saito H, Yokose T, Sakuma Y,
Murakami S, Kondo T, Oshita F, Ito H, Nakayama H, Yamada K and
Iwazaki M: Relation between thin-section computed tomography and
clinical findings of mucinous adenocarcinoma. Ann Thorac Surg.
99:975–981. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hata A, Katakami N, Fujita S, Kaji R, Imai
Y, Takahashi Y, Nishimura T, Tomii K and Ishihara K: Frequency of
EGFR and KRAS mutations in Japanese patients with lung
adenocarcinoma with features of the mucinous subtype of
bronchioloalveolar carcinoma. J Thorac Oncol. 5:1197–1200. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shim HS, Kenudson M, Zheng Z, Liebers M,
Cha YJ, Ho Q Hoang, Onozato M, Phi Le L, Heist RS and Iafrate AJ:
Unique Genetic and survival characteristics of invasive mucinous
adenocarcinoma of the lung. J Thorac Oncol. 10:1156–1162. 2015.
View Article : Google Scholar : PubMed/NCBI
|
